Heart Failure / 心力衰竭

Definition

Heart failure is a clinical syndrome in which cardiac structural or functional impairment prevents the heart from supporting circulation adequately, producing symptoms, signs, and risk to other organs; it can emerge acutely or persist chronically with periods of decompensation.

Current Synthesis

The current source frames heart failure as a downstream syndrome rather than one isolated disease or an inevitable feature of old age. Hypertension and coronary disease are prominent upstream pathways, while myocardial infarction, cardiomyopathy, myocarditis, valve disease, metabolic disease, pregnancy-related cardiomyopathy, age, and inherited risk show its heterogeneity. Breathlessness, reduced exercise tolerance, edema, orthopnea, waking short of breath, fatigue, abdominal or appetite change, palpitations, and dizziness gain meaning through their pattern, examination, biomarkers, imaging, and cause review. Treatment is therefore layered: stabilize congestion and circulation, establish the phenotype and cause, apply eligible disease-modifying therapy, address reversible cardiac disease, and sustain monitoring and follow-up.

Key Claims

• Heart failure can affect younger as well as older people and can be acute, chronic stable, or acutely decompensated.
• Hypertension and coronary disease are major upstream pathways, but no single cause or phenotype represents the whole syndrome.
• Symptoms commonly cluster; inability to lie flat, severe breathlessness, marked edema, or reduced urine warrants urgent assessment.
• Diagnosis joins symptoms and examination with objective evidence such as BNP or NT-proBNP and echocardiography.
• Cause and phenotype shape therapy, including whether medication, revascularization, valve treatment, devices, or other specialist interventions are appropriate.
• The four disease-modifying medication classes discussed in the episode mainly concern eligible chronic heart failure with reduced ejection fraction and require individualized titration.
• Long-term outcomes depend on integrated clinical care and self-management, not one drug, procedure, or lifestyle behavior alone.

Evidence

• Risk, presentation, and staging: VOL.134心累？别硬撑！心力衰竭危机四伏 connects diverse cardiac causes to acute and chronic presentation, A-to-D disease stages, symptom combinations, and urgent deterioration signals.
• Diagnosis and phenotype: VOL.134心累？别硬撑！心力衰竭危机四伏 places examination, natriuretic-peptide testing, and echocardiography beside clinical symptoms.
• Layered treatment: VOL.134心累？别硬撑！心力衰竭危机四伏 describes lifestyle care, eligible disease-modifying medicines, dose titration, cause assessment, revascularization, valve treatment, heart-rate management, and specialist follow-up.

Counterevidence & Qualifications

The evidence is one public-education podcast note rather than a clinical guideline, systematic review, or patient record. Breathlessness, edema, fatigue, cough, abdominal symptoms, palpitations, and dizziness are not specific to heart failure. Exact diagnosis, phenotype, medication eligibility, dose, fluid and salt targets, heart-rate target, activity plan, device indication, pregnancy management, and procedural choice require clinical assessment. Numerical risks and thresholds reported in the episode remain source-scoped.

What Changed

• Created a unified syndrome model linking upstream disease, presentation, objective diagnosis, phenotype, and layered treatment.
• Distinguished heart failure from an older-adult-only condition.
• Preserved the reduced-ejection-fraction boundary around the episode’s four-pillar medication discussion.

Related Concepts

• Heart Failure Self-Management / 心衰自我管理 - translates chronic care into monitoring, daily behaviors, follow-up, and escalation.
• Hypertension Long-Term Management / 高血压长期管理 - controls a major upstream pathway before or alongside heart failure.
• Hypertension Target-Organ Damage / 高血压靶器官损害 - explains chronic cardiac pressure load and progression toward failure.
• Sudden Cardiac Death Risk Stratification / 心脏性猝死风险分层 - adjacent risk pathway for selected cardiomyopathy and severe ventricular dysfunction.
• Remote Cardiac Monitoring and Warning / 远程心脏监测与预警 - device-mediated monitoring branch for selected cardiac patients.
• Medical Risk Management - keeps diagnosis, medication, procedures, and emergency routing clinically bounded.